Â¥
18.23
Oct 9
New Key Statistics Module, Z-Score and F-Score
SZSE:300142 Key Ratios
Market Cap ¥ M | 29,156.12 |
Enterprise Value ¥ M | 25,659.07 |
P/E(ttm) | 217.02 |
PE Ratio without NRI | 55.58 |
Forward PE Ratio | 37.97 |
Price/Book | 3.08 |
Price/Sales | 8.66 |
Price/Free Cash Flow | 569.67 |
Price/Owner Earnings | -- |
Payout Ratio % | 0.03 |
Revenue (TTM) ¥ M | 3,379.00 |
EPS (TTM) ¥ | 0.08 |
Beneish M-Score | -2.69 |
10-y EBITDA Growth Rate % | -- |
5-y EBITDA Growth Rate % | 4.00 |
y-y EBITDA Growth Rate % | -76.80 |
EV-to-EBIT | 98.24 |
EV-to-EBITDA | 98.24 |
PEG | 13.90 |
Shares Outstanding M | 1,599.35 |
Net Margin (%) | 3.99 |
Operating Margin % | 18.29 |
Pre-tax Margin (%) | 7.36 |
Quick Ratio | 2.54 |
Current Ratio | 2.94 |
ROA % (ttm) | 0.87 |
ROE % (ttm) | 1.43 |
ROIC % (ttm) | 5.41 |
Dividend Yield % | 0.06 |
Altman Z-Score | 5.05 |
SZSE:300142 Number of Guru Trades
SZSE:300142 Volume of Guru Trades
Gurus Latest Trades with SZSE:300142
You need a Premium membership or above to view this section.
Take a 7-Day Free Trial
No Available Data
SZSE:300142 is held by these investors
You need a Premium membership or above to view this section.
Take a 7-Day Free Trial
No Available Data
Walvax Biotechnology Co Ltd Insider Transactions
No Available Data